Beatrice Cubitt

2.7k total citations
38 papers, 1.9k citations indexed

About

Beatrice Cubitt is a scholar working on Infectious Diseases, Epidemiology and Animal Science and Zoology. According to data from OpenAlex, Beatrice Cubitt has authored 38 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Infectious Diseases, 16 papers in Epidemiology and 10 papers in Animal Science and Zoology. Recurrent topics in Beatrice Cubitt's work include Viral Infections and Outbreaks Research (19 papers), Viral Infections and Vectors (13 papers) and Virology and Viral Diseases (12 papers). Beatrice Cubitt is often cited by papers focused on Viral Infections and Outbreaks Research (19 papers), Viral Infections and Vectors (13 papers) and Virology and Viral Diseases (12 papers). Beatrice Cubitt collaborates with scholars based in United States, Germany and Japan. Beatrice Cubitt's co-authors include Juan Carlos de la Torre, Daniel Gonzalez‐Dunia, Luis Martínez‐Sobrido, Adolfo Garcı́a-Sastre, Friedrich A. Grässer, Yusuke Yanagi, M B Oldstone, Catherine Z. Chen, Wei Zheng and Guo‐li Ming and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Immunity and Journal of Virology.

In The Last Decade

Beatrice Cubitt

37 papers receiving 1.8k citations

Peers

Beatrice Cubitt

EPIDE

ASZ

VIROL

GENET

Christian Sauder United States

Jürgen Hausmann Germany

Guido van Marle Canada

Glenn F. Rall United States

Hans Nitschko Germany

Jürgen A. Richt United States

Giuseppe Bertoni Switzerland

Cyrille Mathieu France

Abigail L. Smith United States

Mutsuyo Takayama‐Ito Japan

Christian Sauder United States

Beatrice Cubitt

964 ×0.9

EPIDE

414 ×0.5

228 ×0.6

ASZ

342 ×1.1

VIROL

198 ×0.7

GENET

Citations per year, relative to Beatrice Cubitt Beatrice Cubitt (= 1×) peers Christian Sauder

Countries citing papers authored by Beatrice Cubitt

Since Specialization

Citations

This map shows the geographic impact of Beatrice Cubitt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beatrice Cubitt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beatrice Cubitt more than expected).

Fields of papers citing papers by Beatrice Cubitt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beatrice Cubitt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beatrice Cubitt. The network helps show where Beatrice Cubitt may publish in the future.

Co-authorship network of co-authors of Beatrice Cubitt

This figure shows the co-authorship network connecting the top 25 collaborators of Beatrice Cubitt. A scholar is included among the top collaborators of Beatrice Cubitt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Beatrice Cubitt. Beatrice Cubitt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cubitt, Beatrice, Eva Martínez de Castro, Marı́a M. Lorenzo, et al.. (2025). Repurposing Drugs for Synergistic Combination Therapies to Counteract Monkeypox Virus Tecovirimat Resistance. Viruses. 17(1). 92–92. 9 indexed citations

Heide, Verena van der, Bennett Davenport, Beatrice Cubitt, et al.. (2025). Prolonged but finite antigen presentation promotes reversible defects of “helpless” memory CD8+ T cells. Immunity. 58(7). 1742–1761.e14. 1 indexed citations

Cubitt, Beatrice, et al.. (2025). Flunarizine as a Candidate for Drug Repurposing Against Human Pathogenic Mammarenaviruses. Viruses. 17(1). 117–117.

Cubitt, Beatrice, et al.. (2024). Cellular N-Myristoyl Transferases Are Required for Mammarenavirus Multiplication. Viruses. 16(9). 1362–1362. 2 indexed citations

Carey, Brian D., Shuǐqìng Yú, Chengjin Ye, et al.. (2024). A Lassa virus live attenuated vaccine candidate that is safe and efficacious in guinea pigs. npj Vaccines. 9(1). 220–220. 4 indexed citations

Sakabe, Saori, et al.. (2023). Chaperonin TRiC/CCT Participates in Mammarenavirus Multiplication in Human Cells via Interaction with the Viral Nucleoprotein. Journal of Virology. 97(2). e0168822–e0168822. 5 indexed citations

Cubitt, Beatrice, et al.. (2022). The Pan-ErbB tyrosine kinase inhibitor afatinib inhibits multiple steps of the mammarenavirus life cycle. Virology. 576. 83–95. 2 indexed citations

Cubitt, Beatrice, et al.. (2021). Lassa Virus Vaccine Candidate ML29 Generates Truncated Viral RNAs Which Contribute to Interfering Activity and Attenuation. Viruses. 13(2). 214–214. 14 indexed citations

Kim, Yu-Jin, Beatrice Cubitt, Yíngyún Caì, et al.. (2020). Novel Dihydroorotate Dehydrogenase Inhibitors with Potent Interferon-Independent Antiviral Activity against Mammarenaviruses In Vitro. Viruses. 12(8). 821–821. 6 indexed citations

10.

Jacob, Fadi, Sarshan R. Pather, Wei‐Kai Huang, et al.. (2020). Human Pluripotent Stem Cell-Derived Neural Cells and Brain Organoids Reveal SARS-CoV-2 Neurotropism Predominates in Choroid Plexus Epithelium. Cell stem cell. 27(6). 937–950.e9. 317 indexed citations

11.

Cubitt, Beatrice, Emilio Ortiz-Riaño, Yu-Jin Kim, et al.. (2019). A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity. Antiviral Research. 173. 104667–104667. 10 indexed citations

12.

Kim, Yu-Jin, Beatrice Cubitt, Emily Chen, et al.. (2019). The ReFRAME library as a comprehensive drug repurposing library to identify mammarenavirus inhibitors. Antiviral Research. 169. 104558–104558. 25 indexed citations

13.

Urata, Shuzo, Elizabeth Kenyon, Debasis Nayak, et al.. (2018). BST-2 controls T cell proliferation and exhaustion by shaping the early distribution of a persistent viral infection. PLoS Pathogens. 14(7). e1007172–e1007172. 14 indexed citations

14.

Miranda, Pedro O., et al.. (2018). Mining a Kröhnke Pyridine Library for Anti-Arenavirus Activity. ACS Infectious Diseases. 4(5). 815–824. 9 indexed citations

15.

Martínez‐Sobrido, Luis, et al.. (2009). Identification of Amino Acid Residues Critical for the Anti-Interferon Activity of the Nucleoprotein of the Prototypic Arenavirus Lymphocytic Choriomeningitis Virus. Journal of Virology. 83(21). 11330–11340. 102 indexed citations

16.

Martínez‐Sobrido, Luis, et al.. (2007). Differential Inhibition of Type I Interferon Induction by Arenavirus Nucleoproteins. Journal of Virology. 81(22). 12696–12703. 156 indexed citations

17.

Cubitt, Beatrice, et al.. (1997). Amantadine does not have antiviral activity against Borna disease virus. Archives of Virology. 142(10). 2035–2042. 30 indexed citations

18.

Torre, Juan Carlos de la, Daniel Gonzalez‐Dunia, Beatrice Cubitt, et al.. (1996). Detection of Borna Disease Virus Antigen and RNA in Human Autopsy Brain Samples from Neuropsychiatric Patients. Virology. 223(2). 272–282. 104 indexed citations

19.

Cubitt, Beatrice, et al.. (1994). RNA splicing contributes to the generation of mature mRNAs of Borna disease virus, a non-segmented negative strand RNA virus. Virus Research. 34(1). 69–79. 65 indexed citations

20.

Yanagi, Yusuke, Beatrice Cubitt, & M B Oldstone. (1992). Measles virus inhibits mitogen-induced T cell proliferation but does not directly perturb the T cell activation process inside the cell. Virology. 187(1). 280–289. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact